Kerry Bone Seminar – New Herbal Insights into Allergy and Inflammation
1 June @ 10:30 am - 4:30 pm BST
With the clinical focus on curcumin as the go to herbal treatment for any type of inflammation, do willow bark and Boswellia have any clinical relevance beyond osteoarthritis, and have they even been superseded for this? Is willow bark just a type of mild herbal aspirin, with all of the side effects, but fewer of the benefits of the drug?
In this presentation, Kerry will review new experimental and clinical evidence supporting the important role of these two herbs in a wide range of therapeutic challenges. In particular, new insights are explored that challenge the common assumptions about clinical uses, mechanisms of action and quality issues.
The presentation will close with the proposition that the rehabilitative potential of these two herbs is currently grossly underestimated, and then invite questions and discussions about how we can maximise their clinical potential for the benefit of our patients.
In this presentation you will learn:
- Why willow bark is NOT a type of herbal aspirin
- A new key target for willow bark involving an important “danger” signalling pathway in the innate immune system
- The role of both herbs in autoimmunity
- The role of both herbs in lung disease
- The relationship of Boswellia to the blood brain barrier, and resultant implications for neuroplasticity
- Why it is important to use whole Boswellia extracts
- Why it is important to meet a defined dosage threshold for willow bark
Key Herbal Strategies for Atopy, Asthma and Allergic Rhinitis
There was little awareness of allergic disease before the first description of allergic rhinitis (AR) in 1870. Since then, there have been steep rises in asthma incidence from the 1950s, and more recently, peanut allergy from the 1990s. Clearly, as our lifestyles move more and more away from nature we are experiencing a pandemic of atopy. But what is specifically behind this phenomenon? In the first part of this presentation, the evidence supporting a range of factors contributing to atopy is outlined, together with natural strategies for both managing and preventing allergic disease. In the second part, the specific causes, pathology, clinical presentation and natural treatment of asthma and AR are detailed, together with case histories.
In this comprehensive presentation you will learn about:
The significance of immune danger and toxins as drivers of atopy, and strategies to alleviate these
- Optimising barrier function to mitigate all atopic disease
- How the hygiene and “old friends” hypotheses inform natural strategies for atopy
- The key herbs for managing atopy